Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NCI files protocol for phase I/II clinical trial of Oncolytics' cancer drug Reolysin

Jan. 4, 2008

Positive results reported for Zybrestat in platinum-resistant ovarian cancer

Jan. 3, 2008

NeoPharm files IND for novel docetaxel liposomal delivery system

Jan. 3, 2008

Cyclacel initiates phase II clinical trial of sapacitabine in elderly patients with AML

Jan. 2, 2008

Cephalon submits NDA to FDA for Treanda for relapsed indolent non-Hodgkin's lymphoma

Jan. 2, 2008

Millennium receives material sales milestone for Velcade

Jan. 2, 2008

Patient accrual completed in phase II nimotuzumab trial in colorectal cancer

Jan. 2, 2008

Interim safety analysis supports continuation of phase II PROPEL trial

Jan. 2, 2008

PharmaMar's Yondelis completes requirements for launch in Spain

Dec. 31, 2007

Endocyte and R&D-Biopharmaceuticals enter tubulysin chemo agent agreement

Dec. 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...